In a previous study we observed that the inhibition of the Wnt canonical pathway can be efficient in lowering glycolytic activity in oral cancer cells, including SCC-25 cells, in which it enhanced the effect of the Akt inhibitor [11]. This evidence concerns the gene AKT1 and lip and oral cavity carcinoma.